๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein

โœ Scribed by I. Bruce Rosenzweig; Donald A. Wiebe; Jacquelyn A. Hank; John J. Albers; Janet L. Adolphson; Ernest Borden; Earl S. Shrago; Paul M. Sondel

Publisher
Springer
Year
1990
Tongue
English
Weight
592 KB
Volume
2
Category
Article
ISSN
0921-299X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Thalidomide reduces serum C-reactive pro
Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy
โœ Igal Kedar; Wilmosh Mermershtain; Hefziba Ivgi ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 341 KB

## Abstract Interleukinโ€2 (ILโ€2) has some antitumor activity in patients with renal cell carcinoma. It has been noted that response to ILโ€2 and prognosis may be adversely affected by elevated serum levels of Cโ€reactive protein (CRP) or interleukinโ€6 (ILโ€6). We used thalidomide to treat patients wit

Activators of protein kinase C and 5-aza
Activators of protein kinase C and 5-azacytidine induce IL-2 receptor expression on human T lymphocytes
โœ Joel M. Depper; Warren J. Leonard; Cynthia L. Drogula; Martin Krรถnke; Thomas A. ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 598 KB

Resting human T lymphocytes do not express receptors for interleukin-2, but expression is rapidly induced by exposure to PHA. After maximal expression 2-3 days after stimulation, a progressive decline in receptor number is observed. Receptor expression can be augmented by reexposure to PHA. In this